Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of cell population proliferation and regulation of transcription by RNA polymerase II. Located in cytoplasm and nucleus. Expressed in AB lineage cell and C lineage cell. Human ortholog(s) of this gene implicated in branchiooculofacial syndrome and dilated cardiomyopathy. Is an ortholog of human TFAP2A (transcription factor AP-2 alpha).
Predicted to be involved in intracellular transport and protein secretion. Predicted to be located in Golgi membrane. Is an ortholog of human TMEM167A (transmembrane protein 167A).
Predicted to enable UDP-glycosyltransferase activity. Predicted to be involved in protein O-linked glycosylation. Predicted to be located in membrane. Is an ortholog of human B3GALT1 (beta-1,3-galactosyltransferase 1).
Predicted to enable interleukin-17 receptor activity. Involved in positive regulation of locomotion and response to oxygen levels. Located in plasma membrane. Part of receptor complex. Expressed in RMGL and RMGR. Human ortholog(s) of this gene implicated in immunodeficiency 51. Is an ortholog of human IL17RA (interleukin 17 receptor A) and IL17RB (interleukin 17 receptor B).
Predicted to enable proton-transporting ATPase activity, rotational mechanism. Involved in embryo development; embryonic body morphogenesis; and regulation of syncytium formation by plasma membrane fusion. Located in apical junction complex and apical plasma membrane. Expressed in excretory cell; hypodermal cell; and intestine. Is an ortholog of human ATP6V0E2 (ATPase H+ transporting V0 subunit e2).
Predicted to enable microtubule binding activity. Involved in chromosome segregation. Predicted to be located in microtubule cytoskeleton. Expressed in germ line and sperm.